ArticleBMC infectious diseases2025
Co-infection of active pulmonary tuberculosis and invasive pulmonary aspergillosis following a liver transplant: a case report.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe report a rare case of co-infection involving pulmonary tuberculosis and invasive aspergillosis following a liver transplant. CASE PRESENTATION: A 25-year-old female housewife immigrant from Afghanistan, who had autoimmune hepatitis and underwent a liver transplant, presented with a history of fever and cough for over a month. Probable diagnosis of pulmonary tuberculosis and invasive aspergillosis was made by chest CT, as evidenced by a positive AFB and aspergillosis smear, and MTB PCR, along with the presence of galactomannan antigen in the BAL fluid. The patient improved after 9 months of treatment with anti-tuberculosis and anti-fungal.
conclusionsIn an endemic setting, the probability of pulmonary tuberculosis is elevated, and co-infection with invasive pulmonary aspergillosis, though rare, is significantly more complex. Early detection and targeted management are crucial for improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.